Authors:
GAO Y
MORITA I
MARUO N
KUBOTA T
MUROTA S
ASO T
Citation: Y. Gao et al., EXPRESSION OF IL-6 RECEPTOR AND GP130 IN MOUSE BONE-MARROW CELLS DURING OSTEOCLAST DIFFERENTIATION, Bone, 22(5), 1998, pp. 487-493
Authors:
KOBAYASHI Y
TAKAHASHI Y
CHIKAYAMA S
IKEDA M
UOSHIMA N
KIMURA S
TANAKA K
WADA K
OZAWA M
SUGANO T
MARUO N
KONDO M
Citation: Y. Kobayashi et al., COMPARISON OF THE DNA CONTENT OF MEGAKARYOCYTES IDENTIFIED IMMUNOLOGICALLY WITH THAT IDENTIFIED MORPHOLOGICALLY, HISTOCHEM C, 108(2), 1997, pp. 115-120
Citation: N. Maruo, JAPANESE MANAGEMENT-PRACTICES - THEIR IMPLICATION ON PRODUCTIVITY, EMPLOYMENT AND INCOME-DISTRIBUTION, International journal of production economics, 52(1-2), 1997, pp. 105-115
Authors:
SHIBUYA A
SAITOH S
SAIGENJI K
MARUO N
TAKAHASHI T
Citation: A. Shibuya et al., A NOVEL ASSAY SYSTEMS FOR SERUM TYPE-4 COLLAGEN LEVEL TO SERVE AS A MARKER OF HEPATIC-FIBROSIS, Hepatology, 26(4), 1997, pp. 1893-1893
Citation: N. Maruo et al., EVALUATION OF COMBINED CARDIAC MARKERS ON THE TOSOH AIA NEX IA AUTOMATED IMMUNOASSAY ANALYZER, Clinical chemistry, 43, 1997, pp. 64-64
Citation: K. Igarashi et al., DEVELOPMENT OF A STAT MYOGLOBIN ASSAY ON THE TOSOH AIA NEX IA AUTOMATED IMMUNOASSAY, Clinical chemistry, 43, 1997, pp. 248-248
Authors:
UNO K
NAKANO K
MARUO N
ONODERA H
MATA H
KUROSU I
AKATANI K
IKEGAMI N
KISHI A
YASUDA Y
TANAKA K
SETOGUCHI J
KONDO M
MURAMATSU S
KISHIDA T
Citation: K. Uno et al., DETERMINATION OF INTERFERON-ALPHA-PRODUCING CAPACITY IN WHOLE-BLOOD CULTURES FROM PATIENTS WITH VARIOUS DISEASES AND FROM HEALTHY-PERSONS, Journal of interferon & cytokine research, 16(11), 1996, pp. 911-918
Authors:
MARUO N
CHEN JT
OGATA E
SHIRAKI M
MORITA I
Citation: N. Maruo et al., SERUM LEVEL OF SOLUBLE INTERLEUKIN-6 RECEPTOR IS CORRELATED WITH THE CHANGE OF BONE METABOLISM DURING ESTROGEN THERAPY, Journal of bone and mineral research, 11, 1996, pp. 94-94
Authors:
YAMAZAKI K
YAMADA E
KANAJI Y
SHIZUME K
WANG DS
MARUO N
OBARA T
SATO K
Citation: K. Yamazaki et al., INTERLEUKIN-6 (IL-6) INHIBITS THYROID-FUNCTION IN THE PRESENCE OF SOLUBLE IL-6 RECEPTOR IN CULTURED HUMAN THYROID-FOLLICLES, Endocrinology, 137(11), 1996, pp. 4857-4863
Citation: S. Kolarik et N. Maruo, DEVELOPMENT OF A FULLY-AUTOMATED, RANDOM-ACCESS, STAT CK-MB ASSAY FORTHE AIA-SERIES OF IMMUNOASSAY ANALYZERS, Clinical chemistry, 42(6), 1996, pp. 371-371
Authors:
KOBAYASHI Y
UOSHIMA N
KIMURA S
TANAKA K
WADA K
OZAWA M
MARUO N
KONDO M
Citation: Y. Kobayashi et al., RELATIONSHIP BETWEEN MORPHOLOGICAL CLASSIFICATION OF THE DEGREE OF MATURATION AND THE PLOIDY OF MICROMEGAKARYOCYTES IN MYELODYSPLASTIC SYNDROME PATIENTS, International journal of hematology, 61(3), 1995, pp. 117-122
Authors:
CHEN JT
MARUO N
KATO T
HASUMI K
OGATA E
SHIRAKI M
MORITA I
Citation: Jt. Chen et al., SERUM LEVEL OF SOLUBLE INTERLEUKIN-6 RECEPTOR, NOT INTERLEUKIN-6 IS CORRELATED WITH BONE-RESORPTION MARKERS AND LUMBER BONE-MINERAL DENSITYAFTER MENOPAUSE, Journal of bone and mineral research, 10, 1995, pp. 347-347
Authors:
NAKAI H
MISAWA S
TANIWAKI M
HORIIKE S
TAKASHIMA T
SERIU T
NAKAGAWA H
FUJII H
SHIMAZAKI C
MARUO N
AKAOGI T
UIKE N
ABE T
KASHIMA K
Citation: H. Nakai et al., PROGNOSTIC-SIGNIFICANCE OF LOSS OF A CHROMOSOME 17P AND P53 GENE-MUTATIONS IN BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA, British Journal of Haematology, 87(2), 1994, pp. 425-427
Citation: N. Maruo et al., QUANTITATIVE AND QUALITATIVE CHARACTERISTICS OF COLONY-FORMING UNIT-ERYTHROID COLONIES IN MYELODYSPLASTIC SYNDROME PATIENTS, Acta haematologica, 90(1), 1993, pp. 1